Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

Bruce Shook joined Intact Vascular in 2014 as President and CEO. A highly-experienced, medical device executive with more than 30 years of industry experience, Bruce was previously Co-founder, Director, President, and CEO of Neuronetics, which is a privately held medical device company that markets a non-invasive brain stimulation technology for the treatment of depression.

Previously, Shook was Co-founder, Director, President, and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders. Before that, he served as President of Abiomed, where he successfully obtained a PMA approval for the first, FDA-approved ventricular assist device. Bruce developed cardiac pacing and anti-arrhythmia products at Cordis Corporation as well.

Bruce holds advanced degrees in Biomedical Engineering from Columbia University and Business Administration from the MIT Sloan School of Management. He earned a B.S. degree in Chemical Engineering from Penn State University.

Interview Highlights with Bruce Shook

  • After a storied medtech career, the device that Bruce is most proud of.
  • The origin story for the Tack Endovascular System and how it’s different than current peripheral vascular stents.
  • Bruce’s transition from Cordis to Abiomed and what he learned both personally and professionally.
  • Why Bruce decided to pursue an MBA from MIT after his run with Abiomed.
  • How Bruce and his team at Neuron Therapeutics responded after their failed clinical trial.
  • The lessons Bruce learned while trying to gain insurance coverage and reimbursement for the TMS device with Neuronetics.
  • Bruce’s advice for other medtech entrepreneurs that need to raise money beyond the “friends and family” round.
  • Bruce’s favorite business book, the CEO he most admires, and the advice he’d give to his 25-year-old self.

Listen to the Interview with Bruce Shook

Read the Interview with Bruce Shook

Download a copy of the interview transcript right here.

You May Like These Articles

  • Recent
  • Featured
  • Related

How Medtech Companies Should Approach the Consumer Health Market: Interview with Movano CEO John Mastrototaro

Movano CEO John Mastrototaro talks about how medtech companies can build a successful consumer-facing brand while developing products that meet the needs of payers and providers.

How to Apply an Engineering Mindset to Your Medical Device Startup: Interview with Access Vascular CEO Jim Biggins

Access Vascular CEO Jim Biggins shares his strategies for developing a clinical research roadmap, creative commercialization models, and the reasons why clinician access is crucial for medtech entrepreneurs.

4 Key Considerations to Win Over Investors: Interview with Glympse Bio CEO Caroline Loew

Glympse Bio CEO Caroline Loew discusses her “early-and-often” approach to dealing with regulatory issues and shares four things to consider ahead of conversations with potential investors.

Building Relationships, Raising Capital, and Establishing Reimbursement Codes: Interview with Oculogica CEO Rosina Samadani

Oculogica CEO Rosina Samadani on the importance of relationships in the regulatory and reimbursement processes, why first-time entrepreneurs shouldn’t be intimidated by complex procedures, and lessons learned from her experiences raising capital.

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.

Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger

In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.

Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market

In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.

How Medtech Companies Should Approach the Consumer Health Market: Interview with Movano CEO John Mastrototaro

Movano CEO John Mastrototaro talks about how medtech companies can build a successful consumer-facing brand while developing products that meet the needs of payers and providers.

How to Apply an Engineering Mindset to Your Medical Device Startup: Interview with Access Vascular CEO Jim Biggins

Access Vascular CEO Jim Biggins shares his strategies for developing a clinical research roadmap, creative commercialization models, and the reasons why clinician access is crucial for medtech entrepreneurs.

4 Key Considerations to Win Over Investors: Interview with Glympse Bio CEO Caroline Loew

Glympse Bio CEO Caroline Loew discusses her “early-and-often” approach to dealing with regulatory issues and shares four things to consider ahead of conversations with potential investors.

Building Relationships, Raising Capital, and Establishing Reimbursement Codes: Interview with Oculogica CEO Rosina Samadani

Oculogica CEO Rosina Samadani on the importance of relationships in the regulatory and reimbursement processes, why first-time entrepreneurs shouldn’t be intimidated by complex procedures, and lessons learned from her experiences raising capital.